Onco Therapeutics

ISSN 2694-4642Begell House Inc.United States
ScopusSCImagoMatched via identifier

Journal overview

Journal identity
Titles
Onco Therapeutics
Key identifiers
ISSN
2694-4642
eISSN
2694-4650
NLM ID
Not available
Publisher / basic metadata
Publisher
Begell House Inc.
Country
Language
English

Indexing & coverage

Current indexing summary
Scopus
Previously indexed — discontinued

Scopus's Sources record lists this journal as inactive.

Indexing history
Coverage
2021–2022
Indexing services (MEDLINE, Embase)
Not available
Bibliographic inclusion (PubMed)
Not available
Full-text availability (PMC — not an indexing service)
Not available

Metrics

JIF
Not available
SCImago Journal Rank (SJR) — 2025

Source: SCImago Journal & Country Rank — 2025 dataset. SJR is a metric published by SCImago, presented here as reported.

SJR
0.309
Best Quartile
Q3
H-index
3
Subject categories (quartile varies by category)
  • Biotechnology — Q3
  • Biochemistry — Q4
  • Genetics — Q4
  • Molecular Medicine — Q4
More metrics
Coverage
2021–2022
Country
United States
Region
Northern America
Publisher
Begell House Inc.
Open Access
No
Open Access (Diamond)
No
Total documents (current year)
0
Total documents (3 years)
14
Total references
0
Total citations (3 years)
18
Citable documents (3 years)
12
Citations per document (2 years)
0
References per document
0
Source details
Match confidence
Confirmed — two independent ISSNs agree
Matched via ISSN(s)
2694-4642, 2694-4650
SCImago Source ID
21101278665
SCImago Rank (across all SCImago source types)
16891

Publication activity

Publication activity
SCImago
2025
0 observed publications
Latest publication activity observed
—
Current-year activity
Publication activity data not available

Evidence sources: SCImago. SCImago's count is a source-reported aggregate figure; Crossref/OpenAlex/PubMed counts are distinct article records JCF Labs observed via each provider's own free API — none is guaranteed to be that journal's complete output for the year, and providers may disagree (this is expected, not an error). See this journal's own source evidence above for full context.

Subjects & categories

Subjects / categories
Subject area (SCImago)
MeSH (PubMed)
Not available
Coverage / history
Scopus:2021-2022